HK1074444A1 - Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof - Google Patents

Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof

Info

Publication number
HK1074444A1
HK1074444A1 HK05108399A HK05108399A HK1074444A1 HK 1074444 A1 HK1074444 A1 HK 1074444A1 HK 05108399 A HK05108399 A HK 05108399A HK 05108399 A HK05108399 A HK 05108399A HK 1074444 A1 HK1074444 A1 HK 1074444A1
Authority
HK
Hong Kong
Prior art keywords
preparation
therapeutic use
acyloxypyrrolidine
derivatives
acyloxypyrrolidine derivatives
Prior art date
Application number
HK05108399A
Other languages
English (en)
Inventor
Alain Aulombard
Georges Garcia
Antoine Pradines
Claudine Serradeil-Le Gal
Jean Wagnon
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HK1074444A1 publication Critical patent/HK1074444A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK05108399A 2002-07-19 2005-09-23 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof HK1074444A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0209242A FR2842527B1 (fr) 2002-07-19 2002-07-19 Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
PCT/FR2003/002262 WO2004009585A2 (fr) 2002-07-19 2003-07-17 Derives d'acyloxypyrrolidine et leur utilisation en tant que ligands des recepteurs v1b et v1a de avp

Publications (1)

Publication Number Publication Date
HK1074444A1 true HK1074444A1 (en) 2005-11-11

Family

ID=29797610

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108399A HK1074444A1 (en) 2002-07-19 2005-09-23 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof

Country Status (28)

Country Link
US (1) US7202267B2 (is)
EP (1) EP1525198B1 (is)
JP (1) JP4264414B2 (is)
CN (1) CN100425608C (is)
AR (1) AR040571A1 (is)
AT (1) ATE312092T1 (is)
AU (1) AU2003271815B8 (is)
BR (1) BR0312800A (is)
CA (1) CA2492224A1 (is)
DE (1) DE60302670T2 (is)
DK (1) DK1525198T3 (is)
EA (1) EA008444B1 (is)
ES (1) ES2254962T3 (is)
FR (1) FR2842527B1 (is)
HK (1) HK1074444A1 (is)
HR (1) HRP20041231A2 (is)
IL (1) IL165942A (is)
IS (1) IS2487B (is)
ME (1) MEP12408A (is)
MX (1) MXPA05000822A (is)
NO (1) NO20050292L (is)
NZ (1) NZ537615A (is)
PL (1) PL375309A1 (is)
RS (1) RS20050018A (is)
TW (1) TWI274751B (is)
UA (1) UA78805C2 (is)
WO (1) WO2004009585A2 (is)
ZA (1) ZA200500478B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021534A1 (ja) 2003-08-28 2005-03-10 Taisho Pharmaceutical Co., Ltd. 1,3−ジヒドロ−2h−インドール−2−オン誘導体
TW200643015A (en) 2005-03-11 2006-12-16 Akzo Nobel Nv 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
DE102005015957A1 (de) * 2005-03-31 2006-10-05 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
AU2006255009B2 (en) 2005-06-07 2011-10-27 Pharmacopeia L.L.C. Azinone and diazinone V3 inhibitors for depression and stress disorders
JP5256202B2 (ja) 2006-09-11 2013-08-07 エム・エス・ディー・オス・ベー・フェー キナゾリノンおよびイソキノリノンアセトアミド誘導体
CN103864658B (zh) * 2014-03-06 2016-06-15 南京工业大学 氮杂环丁酮衍生物及其制备方法与应用
CN104447489B (zh) * 2014-12-29 2017-01-11 南京工业大学 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804114B1 (fr) * 2000-01-25 2002-03-08 Sanofi Synthelabo Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
IL165942A0 (en) 2006-01-15
US7202267B2 (en) 2007-04-10
US20050192335A1 (en) 2005-09-01
CN100425608C (zh) 2008-10-15
IS7641A (is) 2005-01-12
DE60302670D1 (de) 2006-01-12
CN1681806A (zh) 2005-10-12
CA2492224A1 (en) 2004-01-29
AU2003271815B8 (en) 2009-04-30
NZ537615A (en) 2006-11-30
WO2004009585A3 (fr) 2004-05-06
IS2487B (is) 2008-12-15
AU2003271815A1 (en) 2004-02-09
MXPA05000822A (es) 2005-08-29
AR040571A1 (es) 2005-04-13
ZA200500478B (en) 2006-07-26
RS20050018A (en) 2007-06-04
NO20050292L (no) 2005-04-19
JP4264414B2 (ja) 2009-05-20
FR2842527B1 (fr) 2005-01-28
HRP20041231A2 (en) 2005-02-28
AU2003271815B2 (en) 2009-03-12
PL375309A1 (en) 2005-11-28
DK1525198T3 (da) 2006-04-18
EA008444B1 (ru) 2007-06-29
TW200410957A (en) 2004-07-01
EP1525198A2 (fr) 2005-04-27
IL165942A (en) 2010-04-15
FR2842527A1 (fr) 2004-01-23
EP1525198B1 (fr) 2005-12-07
WO2004009585A2 (fr) 2004-01-29
UA78805C2 (en) 2007-04-25
MEP12408A (en) 2010-06-10
TWI274751B (en) 2007-03-01
ES2254962T3 (es) 2006-06-16
BR0312800A (pt) 2005-04-19
ATE312092T1 (de) 2005-12-15
JP2005537271A (ja) 2005-12-08
DE60302670T2 (de) 2006-09-07
EA200500032A1 (ru) 2005-08-25

Similar Documents

Publication Publication Date Title
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
HRP20040027A2 (en) 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
ZA200700705B (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL172733A0 (en) Diphenylpyridine derivatives, preparation and therapeutic application thereof
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
HK1074446A1 (en) 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
PT1525193E (pt) Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
IL156647A0 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
PL374858A1 (en) Novel arylimidazole derivatives, preparation and therapeutic uses thereof
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
HK1107340A1 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
SI1525198T1 (sl) Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP
SI1525193T1 (sl) Acilaminotiazolni derivati in njihova uporaba kotinhibitorji beta-amiloida
SI1513836T1 (sl) Derivati piperazinilacilpiperidina, njihova priprava in njihova terapevtska uporaba
SI1513835T1 (sl) Derivati piperazunilacilpiperidina, njihova priprava in njihova terapevtska uporaba
IL165420A0 (en) Piperazinylacylpiperidine derivatives their preparation and therapeutic use thereof
IL156593A0 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2002355351A1 (en) Acylaminothiazole derivatives, their preparation and therapeutic use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120717